These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7478439)

  • 1. Primary T cell leptomeningeal lymphoma--successful treatment with systemic chemotherapy.
    Yeh KH; Cheng AL; Tien HF
    Oncology; 1995; 52(6):501-4. PubMed ID: 7478439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol.
    Cheng AL; Yeh KH; Uen WC; Hung RL; Liu MY; Wang CH
    Cancer; 1998 May; 82(10):1946-51. PubMed ID: 9587129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab.
    Huang HC; Cheng AL; Lin CW; Kuo SH
    Ann Hematol; 2013 Jul; 92(7):989-92. PubMed ID: 23242476
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary meningeal lymphoma of T-cell origin: a rare presentation of primary central nervous system lymphomas.
    Ponce J; Segura A; Gimenez A; Diaz R; Molina J; Palomar L; Codina JG
    Clin Lymphoma Myeloma; 2007 Sep; 7(8):546-9. PubMed ID: 18021474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary natural killer/T-cell lymphoma presenting as leptomeningeal disease.
    Liao B; Kamiya-Matsuoka C; Gong Y; Chen M; Wolf BA; Fowler NH
    J Neurol Sci; 2014 Aug; 343(1-2):46-50. PubMed ID: 24880537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary leptomeningeal T-cell lymphoblastic lymphoma: a rare cause of chronic meningitis.
    Elavarasi A; Bhatia R; Arava S; Kumar L
    BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32958553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.
    Haioun C; Lepage E; Gisselbrecht C; Salles G; Coiffier B; Brice P; Bosly A; Morel P; Nouvel C; Tilly H; Lederlin P; Sebban C; Brière J; Gaulard P; Reyes F
    J Clin Oncol; 2000 Aug; 18(16):3025-30. PubMed ID: 10944137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
    Colombat P; Lemevel A; Bertrand P; Delwail V; Rachieru P; Brion A; Berthou C; Bay JO; Delepine R; Desablens B; Camilleri-Broët S; Linassier C; Lamy T
    Bone Marrow Transplant; 2006 Sep; 38(6):417-20. PubMed ID: 16951691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
    Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
    Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
    Morra E; Lazzarino M; Inverardi D; Brusamolino E; Orlandi E; Canevari A; Pagnucco G; Bernasconi C
    J Clin Oncol; 1986 Aug; 4(8):1207-11. PubMed ID: 3461134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
    Abrey LE; Moskowitz CH; Mason WP; Crump M; Stewart D; Forsyth P; Paleologos N; Correa DD; Anderson ND; Caron D; Zelenetz A; Nimer SD; DeAngelis LM
    J Clin Oncol; 2003 Nov; 21(22):4151-6. PubMed ID: 14615443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric primary leptomeningeal lymphoma treated without cranial radiotherapy.
    Taga T; Sakaue Y; Anzai Y; Takeuchi Y; Ohta S
    Pediatr Blood Cancer; 2007 Apr; 48(4):477-8. PubMed ID: 16411209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Sweetenham JW; Mead GM; Whitehouse JM
    J Clin Oncol; 1991 Dec; 9(12):2202-9. PubMed ID: 1720454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.
    Rigacci L; Carrai V; Nassi L; Alterini R; Longo G; Bernardi F; Bosi A
    Cancer; 2005 Mar; 103(5):970-7. PubMed ID: 15666323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
    Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
    Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
    Fetscher S; Lübbert M; Kanz L; Behringer D; Finke J; Mertelsmann R; Lange W
    Bone Marrow Transplant; 1997 Mar; 19(5):527-8. PubMed ID: 9052926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ongoing remission after intensive ALL-type chemotherapy in pediatric intestinal T-cell lymphoma.
    Friedrich C; Schrum J; Chott A; Janka-Schaub G; Kabisch H
    Pediatr Blood Cancer; 2010 Apr; 54(4):610-2. PubMed ID: 20049930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.